Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Scoop Today USA journalist was involved in the writing and production of this article.
CoreAge Rx Expands Access to Weight Loss Solutions with Compounded GLP-1 Medications
United States, 20th Nov 2025 — CoreAge Rx, a leading telehealth pharmacy dedicated to providing personalized and accessible medication solutions, today announced the expanded availability of compounded tirzepatide and semaglutide for patients seeking safe and effective weight management options. This development comes at a time of heightened nationwide demand for GLP-1 receptor agonist medications, as many individuals continue to face rising costs and supply shortages of commercially available products.
GLP-1 medications—including tirzepatide and semaglutide—have become widely recognized for their clinically significant role in supporting weight reduction, improving metabolic health, and assisting patients with obesity-related concerns. With demand continuing to outpace supply, patients often struggle to obtain timely prescriptions or face prohibitive pricing. CoreAge Rx’s compounded alternatives are designed to bridge this gap by offering a cost-effective and accessible option while maintaining strict quality and safety standards.
“Patients deserve dependable access to the treatments that support their long-term health,” said Ella Jones, spokesperson for CoreAge Rx. “By expanding availability of compounded tirzepatide and semaglutide, we are ensuring that people who rely on these medications are not left behind during ongoing shortages. Our mission is to make advanced weight management solutions more affordable and more attainable for patients across the United States.”
As a telehealth-focused pharmacy, CoreAge Rx integrates virtual consultations, secure prescriptions, and home delivery to streamline the patient experience from start to finish. The addition of compounded GLP-1 medications further enhances its commitment to offering transparent, personalized, and patient-centered care. Compounded medications are prepared in licensed compounding facilities and formulated specifically to meet patient needs when FDA-approved options are unavailable or in shortage.
This expanded service is particularly timely, as millions of Americans continue to explore medically supported weight-loss strategies amid increasing awareness of obesity and metabolic health challenges. CoreAge Rx’s approach combines clinical oversight with advanced pharmaceutical compounding practices to ensure patients receive medications tailored to their unique health goals.
In addition to addressing supply challenges, CoreAge Rx emphasizes patient education as a key component of its services. Patients receiving compounded tirzepatide or semaglutide benefit from guidance on dosing, expectations, lifestyle adjustments, and ongoing monitoring. The company’s clinical team works directly with each patient to support sustained progress and encourage long-term health improvements.
“Weight management is not a one-size-fits-all journey,” Jones added. “By offering safe compounded options alongside dedicated telehealth support, we enable patients to pursue treatment plans that align with their needs, preferences, and medical history. Our expanded GLP-1 program reflects our commitment to empowering patients through high-quality care and innovation.”
CoreAge Rx continues to expand its offerings as part of its mission to redefine pharmaceutical accessibility through telehealth. The introduction of compounded GLP-1 medications represents a major step forward in ensuring equitable access to one of the most effective modern weight-loss therapies available today.
Patients interested in learning more about compounded tirzepatide, semaglutide, or other personalized treatment options can connect with the CoreAge Rx team through its secure online platform.
For more information visit https://www.coreagerx.com .
About CoreAge Rx
CoreAge Rx is a U.S.-based telehealth pharmacy specializing in personalized, accessible, and cost-effective medication solutions. With a focus on convenience, clinical oversight, and patient-centered care, CoreAge Rx provides compounded medications, telehealth consultations, and home delivery services that support long-term health and wellness. The company is committed to expanding access to innovative therapies through transparent and reliable pharmacy services.
Media Contact
Organization: CoreAge Rx
Contact Person: Ella Jones
Website: https://www.coreagerx.com/
Email: Send Email
Country:United States
Release id:37325
The post CoreAge Rx Expands Access to Weight Loss Solutions with Compounded GLP-1 Medications appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
